Insider Transactions in Q2 2025 at Blueprint Medicines Corp (BPMC)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 18
2025
|
Lynn Seely |
BUY
Grant, award, or other acquisition
|
Direct |
3,902
+18.53%
|
$499,456
$128.12 P/Share
|
|
Jun 18
2025
|
Mark Alan Goldberg |
BUY
Grant, award, or other acquisition
|
Direct |
3,902
+14.97%
|
$499,456
$128.12 P/Share
|
|
Jun 18
2025
|
Jeffrey W. Albers |
BUY
Grant, award, or other acquisition
|
Direct |
3,902
+2.53%
|
$499,456
$128.12 P/Share
|
|
Jun 18
2025
|
John Tsai |
BUY
Grant, award, or other acquisition
|
Direct |
3,902
+23.58%
|
$499,456
$128.12 P/Share
|
|
Jun 18
2025
|
Lonnel Coats |
BUY
Grant, award, or other acquisition
|
Direct |
3,902
+38.84%
|
$49,992,424
$12812.0 P/Share
|
|
Jun 18
2025
|
Habib J Dable |
BUY
Grant, award, or other acquisition
|
Direct |
3,902
+23.58%
|
$499,456
$128.12 P/Share
|
|
Jun 18
2025
|
Alexis Borisy |
BUY
Grant, award, or other acquisition
|
Direct |
3,902
+4.76%
|
$499,456
$128.12 P/Share
|
|
Jun 18
2025
|
Daniella Beckman |
BUY
Grant, award, or other acquisition
|
Direct |
3,902
+20.93%
|
$499,456
$128.12 P/Share
|
|
Jun 03
2025
|
Percy H. Carter CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
2,659
-2.35%
|
$337,693
$127.88 P/Share
|
|
May 27
2025
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
5,000
-1.66%
|
$505,000
$101.47 P/Share
|
|
May 27
2025
|
Jeffrey W. Albers |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+3.19%
|
$180,000
$36.05 P/Share
|
|
May 19
2025
|
Christina Rossi CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
2,274
-1.14%
|
$227,400
$100.84 P/Share
|
|
May 05
2025
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
2,752
-4.84%
|
$283,456
$103.62 P/Share
|
|
May 05
2025
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,752
+12.26%
|
$148,608
$54.13 P/Share
|
|
May 05
2025
|
Christina Rossi CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
2,274
-0.83%
|
$231,948
$102.28 P/Share
|
|
Apr 01
2025
|
Kate Haviland CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
2,498
-0.37%
|
$214,828
$86.88 P/Share
|